Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0522213468
Mon, 14.11.2022
Achiko AG
Achiko AG Commences Commercial Deliveries in Indonesia
Commencing Commercial Deliveries of its Generation 2 AptameXTM Covid-19 tests kits with Nahdlatul Ulama DKI in Jakarta, Indonesia
Zurich, 14 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) is proud [ … ]
Mon, 14.11.2022
Achiko AG
Achiko AG Commences Commercial Deliveries in Indonesia
Commencing Commercial Deliveries of its Generation 2 AptameXTM Covid-19 tests kits with Nahdlatul Ulama DKI in Jakarta, Indonesia
Zurich, 14 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) is proud [ … ]
Wed, 02.11.2022
Achiko AG
Achiko AG Production and Company Update
Completing Production Pilot for Generation 2 of AptameXTM as a Precursor to Mass Commercial Production
Expect to Commence Delivery to Sales and Marketing Contract with Nahdlatul Ulama on Commencement of Mass Production
Zurich, 2 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: AC [ … ]
Wed, 02.11.2022
Achiko AG
Achiko AG Production and Company Update
Completing Production Pilot for Generation 2 of AptameXTM as a Precursor to Mass Commercial Production
Expect to Commence Delivery to Sales and Marketing Contract with Nahdlatul Ulama on Commencement of Mass Production
Zurich, 2 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: AC [ … ]
Fri, 07.10.2022
Achiko AG
Achiko AG Appoints New Chief Financial Officer
Zurich, 7 October 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) a healthcare technology company that is developing new innovations and disruptive diagnostic solutions that put people first announced that it has app [ … ]
Fri, 07.10.2022
Achiko AG
Achiko AG Appoints New Chief Financial Officer
Zurich, 7 October 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) a healthcare technology company that is developing new innovations and disruptive diagnostic solutions that put people first announced that it has app [ … ]
Mon, 03.10.2022
Achiko AG
Achiko AG reports first half to 30 June 2022 results and provides corporate update as of 30 September 2022
Achiko reports an EBITDA loss of USD 1.9 million, compared to an EBITDA loss of USD 4.6 million for the 6 months ending 30 June 2021.
Focal points of the first half year were completion of a major new sales contract in Indonesia, obtaining [ … ]
Mon, 03.10.2022
Achiko AG
Achiko AG reports first half to 30 June 2022 results and provides corporate update as of 30 September 2022
Achiko reports an EBITDA loss of USD 1.9 million, compared to an EBITDA loss of USD 4.6 million for the 6 months ending 30 June 2021.
Focal points of the first half year were completion of a major new sales contract in Indonesia, obtaining [ … ]
Tue, 06.09.2022
Achiko AG
Achiko AG Corporate and Operational Update
ACHI shares resumed trading on SIX Swiss Exchange on 1 September after successful completion of Audit and Financing
Key Swiss investors provide CHF 1.3 million via convertible notes
Successful calibration of Generation 2 AptameX™ product
Steven Goh, CEO, to step down upon appointment of successor
Zur [ … ]
Tue, 06.09.2022
Achiko AG
Achiko AG Corporate and Operational Update
ACHI shares resumed trading on SIX Swiss Exchange on 1 September after successful completion of Audit and Financing
Key Swiss investors provide CHF 1.3 million via convertible notes
Successful calibration of Generation 2 AptameX™ product
Steven Goh, CEO, to step down upon appointment of successor
Zur [ … ]